Deciphera Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Industry
Pharmaceutical Preparations
Location
200 Smith Street, Waltham, MA

Insiders trading volume in the past year

Deciphera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brightstar Associates LLC 10%+ Owner $361M Apr 22, 2024
Daniel Lee Flynn Chief Scientific Officer $6.18M Jun 16, 2023
Jama Pitman SVP, Chief Development Officer $0 -$101K -100% Jun 11, 2024
Dashyant Dhanak EVP & Chief Scientific Officer $0 Jun 11, 2024
Matthew L. Sherman EVP & Chief Medical Officer $0 -$185K -100% Jun 11, 2024
Patricia L. Allen Director $0 Jun 11, 2024
Susan L. Kelley Director $0 Jun 11, 2024
Thomas Patrick Kelly Chief Financial Officer $0 -$153K -100% Jun 11, 2024
Steven L. Hoerter President and CEO, Director $0 -$730K -100% Jun 11, 2024
Ron Squarer Director $0 Jun 11, 2024
Edward J. Benz JR Director $0 Jun 11, 2024
John Richard Martin Director $0 Jun 11, 2024
Franklin Stuart Friedman Director $0 Jun 11, 2024
Daniel C. Martin Chief Commercial Officer $0 -$326K -100% Jun 11, 2024
Dennis Leo Walsh Director $0 Jun 11, 2024
James Arthur Bristol Director $0 Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Deciphera Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.